Welcome!

Websphere Authors: RealWire News Distribution, Mark O'Neill, Jayaram Krishnaswamy, Bob Gourley, PR.com Newswire

News Feed Item

The Zacks Analyst Blog Highlights:First Trust US IPO Index, Renaissance IPO ETF, Compuware, CA Technologies and International Business Machines

CHICAGO, March 24, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the First Trust US IPO Index (AMEX:FPX-Free Report), Renaissance IPO ETF (AMEX:IPO-Free Report), Compuware Corp. (Nasdaq:CPWR-Free Report), CA Technologies (Nasdaq:CA-Free Report) and International Business Machines (NYSE:IBM-Free Report).

Zacks Investment Research, Inc., www.zacks.com.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday's Analyst Blog:

Profit from the Booming IPO Market with These ETFs

After a strong 2013, the IPO market continues to be hot this year. High investor demand, low interest rates, rising stock market and improving economy are the main reasons driving the IPO boom. Investors are now much more willing to invest in these fledgling companies, in anticipation of high rewards later.

Some of the highly anticipated IPOs continue to feed the frenzy. The most hyped IPO event this year undoubtedly is the US stock market debut of Chinese e-commerce giant Alibaba. The IPO is likely to be one of the largest in history with an expected valuation of ~$130 billion. (Read: 4 ETFs to Tap on upcoming Alibaba IPO)

Strong Momentum in the IPO Market in 2014

49 deals have been priced so far in 2014, up 81.5%  from the same period last year and proceed raised ($8.0 billion) are up 24.2% from last year, according to Renaissance Capital. That is a strong rebound from the lows seen in 2008, at the height of the financial crisis, when just 31 companies went public.

Looking at the industry breakdown, Healthcare has seen the most offerings (26) this year though the rise has been spread out across various industries. This is nice change from the dot-com bubble days when the IPO space was totally dominated by the tech companies. (Read: 3 Top Ranked ETFs from hottest sectors)

Are all IPOs successful?

Investors hoping to profit from this surge should however remember that not all IPOs are successful.  While a handful of these fledgling companies may turn out to be excellent investments, some may result in big losses.

If you have excellent skills in picking newly public companies, which may later turn out to be like Google, Apple or Tesla, then individual IPOs are the best for you.

But actually investing in smaller, rather unknown companies can be quite risky. 74% of companies that launched IPOs in the last six months have lost money, highest from March 2000, when 80% of new companies were unprofitable.

Further, some valuations are now touching crazy levels. Castlight Health, which debuted last week, now has a market value of $2.7 billion, though it had revenues of just $13 million last year and will not report any profits in near future. At its current price the company has a whopping P/S ratio of 181.8. (See: 2 Rising ETFs with double digit yields)

On the other hand, median IPO in 2014 through February was priced at 14.5 times revenue—which itself is the highest in 14 years.

Case for Investing in IPO ETFs

Most investors should consider IPO ETFs that provide a low-risk and diversified exposure to IPOs, instead of betting on individual stocks.

With their sharp focus on the largest, most liquid and best performing offerings, these ETFs have been handily beating the market.

IPO ETFs provide exposure to newly public companies before they join other core US equity indexes. Most broad market indexes include newly public companies only after a 'seasoning' period—i.e. after they have been trading for some time. For example, Google was included in the S&P 500 index about two years after its debut.

Investors should however note that they will not be able to capture the first day's 'pop' (or drop!) with these ETFs, since they include the newly public stock only after it has been trading for a few days.

Though IPO ETFs do not participate in the first day's 'pop', this strategy reduces their volatility. Many retail investors had suffered losses in Facebook IPO, one of the most hyped IPOs of all times, which fell substantially below its offer price within the first week of trading itself, but   recovered a lot later.

Many investors probably still remember the disastrous performance of some of the 'hot' IPOs from the dot-com era. An ETF approach can largely reduce the risks, while offering the opportunity to participate in the gains of a diversified group of larger, more liquid IPOs.

First Trust US IPO Index (AMEX:FPX-Free Report)

FPX tracks the IPOX-100 U.S. Index, which is a modified value-weighted price index measuring the performance of 100 largest, typically best performing and most liquid U.S. IPOs (including spin-offs).

Currently, the product has a nice mix of sectors, with top four being Consumer Discretionary, IT, Energy and Healthcare. In terms of individual holdings, Facebook (11.0%), AbbVie (8.7%) and General Motors (6.9%) take the top three spots.  

With a 10% cap on all constituents, the fund rules out too much concentration in any single holding. The ETF, which was initiated in 2006, has managed to attract about $570 million in assets so far.  It charges annual expenses of 60 basis points.

The product has crushed the broader market over the last five years, returning 288% compared with 170% for SPY.

Renaissance IPO ETF (AMEX:IPO-Free Report)

IPO tracks the rules-based Renaissance IPO Index which is comprised of the largest and most liquid newly-listed U.S. IPOs.  New companies are included in the index on the fifth day of trading or during quarterly review. They are removed after two years.

Zoetis, Facebook and Workday are the top holdings as of now. This ETF is more top-heavy compared with FPX, with top ten holdings accounting for almost 60% of the asset base. The fund charges an expense ratio of 60 basis points.

The ETF was launched recently, but has been handily beating the broader market since inception.

The Bottom Line

The IPO market is booming this year. But investing in new, untested companies can be risky. ETFs provide a low-risk and convenient way to profit from the IPO boom.

Compuware Attracting Private Equity

Reportedly, private-equity firms Vista Equity Partners LLC and Thoma Bravo LLC are pondering over the buyout of Compuware Corp. (Nasdaq:CPWR-Free Report). This is the second time in last 15 months that Compuware attracted attention from prospective private-equity buyers.

Although no talks between the parties have been reported, according to Bloomberg the company's finances are being reviewed by the duo. Compuware rejected a $3.2 billion bid from activist investor Elliott Management Corp. in January last year.

Post the Elliott offer, Compuware reportedly solicited a number of other private equity funds such as Blackstone Group LP, TPG Capital LP and Golden Gate Capital for a possible buyout. However, to date, nothing concrete has materialized from these discussions.

After rejecting Elliott's offer, Compuware announced a number of initiatives that included cost cutting, divestiture of non-core units, dividend payment and lastly the spin-off of its cloud-based division Covisint into a separate publicly traded unit, Covisint Corp.

On May 16, 2013, Compuware declared its first dividend of 12.5 cents as part of its restructuring program. Covisint started trading as a separate company from Sep 2013. Compuware offered approximately 18% of its stake in the IPO. The company is expected to distribute its remaining shares directly to shareholders within a year of the completion of the IPO.

Earlier this year, Compuware divested three strategic business units — Changepoint, Professional Services and Uniface — which will allow management to focus better on the core business, thereby improving execution. Compuware's restructuring plan is expected to save approximately $110.0–$120.0 million on an annual basis over the next couple of years.

We believe Compuware's initiatives are positive for shareholders over the long term. Compuware expects APM to grow 9.0% in 2014. New program wins and introduction of new products will help Compuware to counter strong competition from the likes of BMC Software and CA Technologies (Nasdaq:CA-Free Report). This also makes the company attractive to private-equity buyers.

However, overdependence on International Business Machines' (NYSE:IBM-Free Report) technology may rationalize growth prospects to a certain extent. Furthermore, the intensely competitive landscape remains a major headwind.

Currently, Compuware has a Zacks Rank #3 (Hold).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on FPX - FREE

Get the full Report on IPO - FREE

Get the full Report on CPWR - FREE

Get the full Report on CA - FREE

Get the full Report on IBM - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.